The Belgian regulatory framework for medical devices is highly complex, and the already dense legal landscape was recently added to by the adoption of two new Belgian royal decrees: the Royal Decree of 25 September 2022 relating to performance studies involving in vitro diagnostic medical devices and the Royal Decree of 13 September 2022 amending
Kristof Roox is co-managing partner of Crowell & Moring’s Brussels Office. He is a partner in the Intellectual Property Group and focuses on IP litigation, and in particular on complex patent litigation in the life sciences sector. With 25 years’ experience, Kristof has an impressive reputation before the Belgian civil and administrative courts, and before regulatory authorities. He is also widely respected for his pragmatic and creative approach to solving business disputes and for his to-the-point counselling.